PEPGEN INC. Shareholders' Equity
PEPGEN INC. (PEPG) had Shareholders' Equity of $119.53 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $119.53M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $133.98M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $147.44M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $163.14M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $119.53M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $133.98M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $147.44M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $163.14M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $71.16M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $91.81M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $118.62M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $137.46M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $155.04M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $179.00M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $108.42M 10-K · filed 2026-03-04 |
| 2023-09-30 | $125.86M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $147.28M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $164.84M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $179.63M 10-K · filed 2025-02-24 |
| 2022-09-30 | $192.94M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $210.22M 10-Q · filed 2023-11-08 |
| 2022-03-31 | -$49.59M 10-Q · filed 2023-11-08 |
| 2021-12-31 | -$32.08M 10-K/A · filed 2024-03-29 |
| 2021-09-30 | -$25.61M 10-Q · filed 2022-11-10 |
| 2021-06-30 | -$17.84M 10-Q · filed 2022-11-10 |
| 2021-03-31 | -$12.78M 10-Q · filed 2022-11-10 |
| 2020-12-31 | -$6.36M 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |